Concepedia

Michael Su

MS

42

Publications

10.2K

Citations

32

H-Index

1993

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Howard Hughes Medical Institute

Agios Pharmaceuticals (United States)

Yale University

Tokyo Metropolitan Institute of Medical Science

Michael Su is an author at Vertex Pharmaceuticals (United States) specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

1993–2023

42

Publications

42

Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9

Keisuke Kuida, Tarik F. Haydar, Chia‐Yi Kuan et al. · Cell · 1998 · 1.6K citations · Full text

Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme

Keisuke Kuida, Judith A. Lippke, George Ku et al. · Science · 1995 · 1.6K citations

, , +17

Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme

Yong Gu, Keisuke Kuida, Hiroko Tsutsui et al. · Science · 1997 · 1.1K citations

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

Elizabeth A. Harrington, David Bebbington, Jeffrey R. Moore et al. · Nature Medicine · 2004 · 948 citations · Full text

, , +11

Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.

Adrian Puren, Giamila Fantuzzi, Yun Gu et al. · Journal of Clinical Investigation · 1998 · 552 citations · Full text

, , +15

Rows per page

1–5 of 42